FDA Center for Drug Evaluation & Research Issues Warning Letter to Revlon Group Holdings
June 11, 2026
June 11, 2026
WASHINGTON, June 11 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Revlon Group Holdings LLC from its Center for Drug Evaluation and Research:
* * *
Recipient: Mr. David Hamilton, Vice President of Operations, Revlon Group Holdings, LLC, 1501 Williamsboro St., Oxford, NC 27565, United States
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
Warn . . .
* * *
Recipient: Mr. David Hamilton, Vice President of Operations, Revlon Group Holdings, LLC, 1501 Williamsboro St., Oxford, NC 27565, United States
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
Warn . . .